Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Autoimmunity|May 7, 2014
1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritisElizabeth Pigott, James B DuHadaway, Alexander J Muller, et al.Cancer Research|August 3, 2007
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophanRichard Metz, James B Duhadaway, Uma Kamasani, et al.Molecular Cancer Therapeutics|June 10, 2010
Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenaseRichard Metz, James B Duhadaway, Sonja Rust, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunityGrant N Scott, James DuHadaway, Elizabeth Pigott, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic MechanismLauren M F Merlo, James B DuHadaway, Samantha Grabler, et al.Cancer Immunology, Immunotherapy : CII|April 9, 2014
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancerGeorge C Prendergast, Courtney Smith, Sunil Thomas, et al.Frontiers in Oncology|September 27, 2018
Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in CancerEric Fox, Thomas Oliver, Melissa Rowe, et al.Ebiomedicine|November 28, 2016
IDO1 is an Integral Mediator of Inflammatory NeovascularizationArpita Mondal, Courtney Smith, James B DuHadaway, et al.Journal of the American College of Surgeons|May 30, 2009
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active targetAgnieszka K Witkiewicz, Christina L Costantino, Richard Metz, et al.Digestive Diseases and Sciences|April 25, 2012
Bin1 attenuation suppresses experimental colitis by enforcing intestinal barrier functionMee Young Chang, Janette Boulden, M Carmen Valenzano, et al.Pageof 6